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Introduction: Children diagnosed with an Autism Spectrum Disorder (ASD) often lack 
the ability to recognize and properly respond to emotional stimuli. These emotional 
deficits are also observed in children with Attention-Deficit Hyperactivity Disorder 
(ADHD), but are often overshadowed by the focus on limited attention span. A growing 
body of research suggests that there may be links between ASD and ADHD, which 
requires further study. Investigation of this hypothesis often relies on the Theory of Mind 
(ToM) construct to frame experiments that explore the relationship between these two 
conditions. Many experiments utilize electroencephalographic (EEG) data to 
quantitatively assess brain activity. The emotional deficits in ASD and ADHD may cause 
a difference within the induced EEG gamma wave burst phenomenon (35-45 Hz) 
produced approximately 300-400 milliseconds following an emotional stimulus. Because 
induced gamma oscillations are not fixed at a definite point in time post-stimulus, 
analysis of averaged EEG data with traditional methods may result in an attenuated 
gamma burst power. Two hypotheses were proposed in this study. First, a software based 
data alignment technique could be employed to reduce the attenuation observed in the 
analysis of these phenomena. Second, improvement of the attenuation would better 
elucidate similarities and differences to stimuli in an experimental study comparing ASD, 
ADHD, and control subjects. 
 
Methods: A study was designed to test the response of a subject to emotional stimuli, 
presented in the form of expressive facial images. In a four part experiment, the subjects 
were instructed to identify gender in the first two blocks of the test, followed by 
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differentiating between basic emotions in the final two blocks (i.e. anger vs. disgust). 
EEG data was collected from ASD (n=10), ADHD (n=9), and control (n=11) subjects via 
a 128 channel EGI system, and processed through a continuous wavelet transform and 
bandpass filter to isolate the gamma frequencies. Data alignment was then employed by 
using a custom MATLAB code to align the individual trials between 200-600 ms post-
stimulus for each subject, EEG site, and condition by maximizing the Pearson product-
moment correlation coefficient between trials within these groups. The gamma power for 
the 400 ms window of maximum induced gamma burst was then calculated and 
compared between subject groups.  
 
Results: Significant main effects for the alignment condition were present across all 
subject groups, experiment conditions, and EEG channels. Significant main effects also 
existed for the experimental condition and subject groups. Condition (anger/disgust 
recognition, gender recognition) x Alignment x Group (ADHD, ASD, Controls) 
interaction was significant across the parietal topographies. These interactions were better 
manifested in the aligned data set.  
 
Conclusions: Both hypotheses were supported by the obtained results. The employed 
data alignment technique significantly reduced the amount of attenuation observed in the 
averaged signals. Additionally, further analysis showed that significant interactions were 
more easily observed in the aligned dataset, which suggests that this technique may be 
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 Autism spectrum disorders (ASD) cover a broad range of early onset 
neurodevelopmental impairments that may be categorized into one of three groups: social 
interactions, communication, and repetitive behaviors (American Psychiatric Association, 
2000). Severity of the symptoms associated with ASD may vary widely from patient to 
patient, leading most clinicians and researchers to view the disorder as a spectrum of 
impairments, which also include Aspberger’s and Pervasive Developmental Disorder-Not 
Otherwise Specified (PDD-NOS) (Chlebowski, Green, Barton, & Fein, 2010; 
Newschaffer et al., 2007). Although ASD was once thought to be a relatively rare 
condition with a prevalence of 2 to 5 children per 10,000, more recent studies have 
suggested that the rate may actually be an order of magnitude greater (Yeargin-Allsopp et 
al., 2003). It is not completely understood whether the rate of prevalence has increased 
over the past several decades or if identification of individuals with ASD has simply 
improved. The average lifetime public expenditure on each individual with ASD is 
estimated to be as high as $4.7 million (Newschaffer et al., 2007). 
 Attention deficit/hyperactivity disorder (ADHD) is another early onset condition 
characterized by inattentiveness and hyperactivity (American Psychiatric Association, 
2000). Classic symptoms of ADHD may include being easily distracted, having difficulty 
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remaining still, frequent boredom, and having difficulty following directions. A 
conglomeration of studies using the most recent guidelines for ADHD reported diagnosis 
rates in school-aged children ranging from 11 to 18 percent in the United States (Faraone, 
Sergeant, Gillberg, & Biederman, 2003). The disorder may continue to affect up to 70 
percent of individuals with juvenile ADHD into adulthood (Knutson & O'Malley, 2010). 
Studies have reported higher costs for families with children who have ADHD, including 
higher direct medical costs and increased hospital visits (Hakkaart-van Roijen et al., 
2007). 
 Both ASD and ADHD are associated with emotional impairments. In ASD, 
emotional deficiencies are a definitive symptom of the disorder. These difficulties 
socializing with other individuals often stem from an inability to quickly and accurately 
read emotional cues and reciprocate with an appropriate response (Begeer, Koot, Rieffe, 
Meerum Terwogt, & Stegge, 2008; Kuusikko et al., 2009; Ryan & Charragáin, 2010). 
Although the focus of ADHD research is often on the more conspicuous inattentiveness 
and hyperactivity observed, a growing interest in the emotional deficits of children with 
ADHD has spurred new studies to explore this question (Da Fonseca, Seguier, Santos, 
Poinso, & Deruelle, 2009). Although this deficiency may be tied back to the original 
problem of inattentiveness (i.e. an inability to focus on reading emotional cues), a recent 
study has suggested that the emotional deficiency may be a separate issue in it of itself 
(Yuill & Lyon, 2007). Emotional deficiencies are typically evaluated with experimental 
visual tasks designed to test the subject’s facial recognition skills, but other studies have 




 While most studies have typically separated ASD and ADHD as unrelated 
phenomena, more recent reviews have justified the comparison of these disorders in a 
combined experimental model (Rommelse, Geurts, Franke, Buitelaar, & Hartman, 2011). 
Genetic investigations have suggested that a common initiator may be responsible for 
ASD and ADHD, and could explain symptoms that indicate a co-morbidity of the two 
disorders (Mulligan et al., 2009; Ronald, Simonoff, Kuntsi, Asherson, & Plomin, 2008). 
Several hypotheses have been proposed to explain the similarities observed in ADHD and 
ASD subjects, including a model that places the two disorders on a larger spectrum of 
social disorders. Further investigation is necessary to support the proposed models. While 
genetic evidence may be an important component of this research, evaluating the 
performance of subjects with these disorders in clinically relevant tasks (i.e. 
facial/emotional recognition) may potentially reveal mechanistic differences between 
similar behaviors in ASD and ADHD, which may challenge or corroborate with other 
findings. 
 These experiments often rely on interpreting the results within the Theory of 
Mind (ToM), which is the method by which an individual assumes another’s perspective 
by characterizing their mental state, or comparing it to their own (Baron-Cohen, 2000). In 
typically developing (TD) children, the theory of mind begins to develop in infancy, with 
notable milestones occurring as early as fifteen months on up through six years of age 
that include the assessment of another’s beliefs, and comprehension of beliefs that may 
be false (Moore & Pure, 1990; Onishi & Baillargeon, 2005; Träuble, Marinovi, & Pauen, 
2010). The ToM construct is frequently applied in the study of ASD (Colle, Baron-
Cohen, & Hill, 2007; Lerner, Hutchins, & Prelock, 2011; Lind & Bowler, 2010) and may 
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explain why autistic children struggle with understanding facial expressions, body 
language, figurative speech, and other social cues that convey emotional information. 
Applications of this theory have been used to assess both the nature and level of 
emotional deficiencies in adults with ASD (Baron-Cohen, Wheelwright, Jolliffe, & 
Therese, 1997).  
 Many studies investigating other conditions have used the ToM to explain their 
findings, including schizophrenia (Bora, Yücel, & Pantelis, 2009), bipolar disorder 
(Wolf, Brüne, & Assion, 2010), chronic depression (Zobel et al., 2010), and ADHD 
(Perner, Kain, & Barchfeld, 2002). Comparing conditions within the context of ToM may 
contribute to a better understanding of both disorders. ToM impairment has been 
compared between ASD and ADHD children in several studies. Tasks requiring children 
to identify the emotions displayed by a person’s face have yielded statistically 
insignificant differences between ADHD and ASD groups (Bühler, Bachmann, Goyert, 
Heinzel-Gutenbrunner, & Kamp-Becker, 2011; Buitelaar, Van Der Wees, Swaab-
Barneveld, & Van Der Gaag, 1999). Another study attempted to use mental cartoons 
(drawings where a character humorously depicting a character’s ignorance or false-belief) 
to find differences between ASD and ADHD adults, and was unable to find significant 
differences between the two groups (Nydén et al., 2010). In some cases, it is unclear 
whether the employed tests are too insensitive to detect differences between disorder 
groups, or whether they truly share a similar level of deficiency. 
 While it may be sufficient for some studies to use easily observable metrics (i.e. 
accuracy of responses to posed questions, reaction times, etc.) to understand ToM 
relationships in neurodevelopmental dysfunction, analysis of the electroencephalographic 
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(EEG) data from subjects with neurodevelopmental disorders provides a top-down 
approach that helps to correlate physiological and behavioral responses. Studies 
involving subjects with ADHD (Koehler et al., 2009; Kovatchev et al., 2001) and ASD 
(Bosl, Tierney, Tager-Flusberg, & Nelson, 2011; Daoust, Lusignan, Braun, Mottron, & 
Godbout, 2008; Oberman et al., 2005) have attempted to identify and explain 
abnormalities in the EEG waveforms, and relate these anomalies to observable 
phenomena within the study, or typical characteristics of the subjects themselves. 
Information gathered from these studies may then be used to form or support theories on 
the development of these disorders, or may be used to characterize the EEG waveforms 
that can be expected to be observed in a particular subject. 
 Several studies have compared the EEG waveforms between ADHD and ASD 
subjects who were either asked to remain still, or perform a particular task. In a study 
using a feedback based learning task, comparison of event-related potentials (ERPs) 
collected during the task provided statistically significant differences between ADHD, 
ASD, and TD children (Groen et al., 2008). Similarly, background abnormalities and 
frequency of localized paroxysmal discharges were found to be a potentially useful 
metric in differentiating PDD (and other forms of ASD) from ADHD (Kawatani et al., 
2012). A study comparing the absolute and relative powers of EEG frequency bands 
between ADHD children with and without additional symptoms characteristic of ASD 
found significant differences in the power levels of these two groups. This would suggest 
that a comorbidity between ASD and ADHD may exist in some children, which opposes 
the current standard of diagnosing these disorders (Clarke, Barry, Irving, McCarthy, & 
Selikowitz, 2011). These findings justify the continued research of comparative EEG 
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waveforms in subjects with ASD, ADHD, and symptoms characteristic of both 
conditions. 
EEG oscillations are separated into several frequency bands, ranging from the 
slower delta waves (0-4 Hz) to the faster gamma waves (30-80 Hz). The gamma 
frequencies, particularly those centered about 40 Hz, have been tied to visual, attentional, 
cognitive, and memory processes (Başar, Schürmann, Başar-Eroglu, & Demiralp, 2001; 
Müller, Gruber, & Keil, 2000). Following a stimulus, two gamma oscillations are 
typically noted: an early evoked oscillation and a late induced oscillation (Başar-Eroglu, 
Strüber, Schürmann, Stadler, & Başar, 1996; Başar, et al., 2001). The evoked gamma 
oscillations typically occur within the first 200 ms after the onset of a stimulus, and are 
locked in time from trial to trial. Because little variation is seen in the latency of the 
evoked gamma with changing stimulus type, it is believed that it may be a result of 
sensory processes. Conversely, induced gamma oscillations occur later, after 240 ms 
post-stimulus, and vary in latency from trial to trial (Tallon-Baudry & Bertrand, 1999). 
These variations may suggest that the induced gamma oscillations are related to higher 
cognitive processes (Tallon-Baudry, 2003). Deviations from typical gamma band activity 
have been reported in several studies on neurological disorders, including epilepsy, 
Alzheimer’s disease, ADHD, and ASD (Herrmann & Demiralp, 2005).  
 Studies have been conducted that observe the gamma EEG frequencies in subjects 
with either ASD or ADHD. A study examining gamma waveforms that occur while 
viewing illusory Kanizsa images suggested that the overall gamma activity increased in 
autistic children (Brown, Gruber, Boucher, Rippon, & Brock, 2005). Another study 
observed general increases in high frequency EEG activity (including gamma 
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frequencies) in boys with autism, and further suggested that this increased activity may 
be proportional to the level of deficiency in each child (Orekhova et al., 2007). In a study 
with ADHD and TD children, no differentiation in the gamma activity was noted between 
new and familiar images by children with ADHD. Conversely, TD children displayed 
different gamma responses depending on the familiarity of the image. This suggests that 
visual memory impairment in ADHD may be associated with this gamma activity (Lenz 
et al., 2010). A Web of Knowledge search at the time of writing produced no known 
studies that have compared gamma activity between ADHD and ASD subjects. Given 
that EEG studies comparing ASD and ADHD while looking at other phenomena have 
produced interesting results, and that ASD and ADHD subjects have individually shown 
statistically different gamma activity compared to TD subjects, it is justifiable to conduct 
a gamma study comparing ASD and ADHD. 
 Since evoked gamma waveforms are synchronized in time post-stimulus, 
averaging analogous trials typically reveals the evoked response in the averaged 
waveform. However, induced gamma waveforms vary in time, and thus, appear to be 
severely attenuated in the averaged response. This makes the analysis of the induced 
gamma activity more complex than evoked gamma activity. Studies looking at gamma 
waveforms have either focused on evoked gamma (Lenz et al., 2008), or found and 
characterized induced gamma activity on a trial by trial basis (Brown, et al., 2005). 
 A potential solution to the variance observed in the induced gamma waveforms 
would be to ‘align’ the signals prior to analysis. Data alignment is a procedure that 
correlates analogous features between two signals or images, and standardizes them so 
they may be more accurately compared to one another (Figure 1). This technique is 
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commonly performed in medical imaging studies, where collected images may differ 
slightly from one another or an amassed source of training data (i.e. level of contrast, 
angle from which the images were taken, relative position of the object of interest, etc.) 
(Casanova et al., 2011; El-Baz et al., 2011). A similarity measure (i.e. correlation, mutual 
information, etc.) is typically used to optimize the alignment process, which reaches an 
absolute maxima when two images are oriented in the most similar fashion. Alignment 
corrects these observed incongruences without changing the nature of the phenomena of 
interest. 
 A similar methodology can be applied to one-dimensional signals as well, such as 
EEG waveforms. Data alignment has also been used in EEG studies to align visual 
evoked potentials with varying latencies via the discrete Fourier transform (Sahin & 
Yilmazer, 2010). A similar technique may be used to align the induced gamma ‘burst’ 
that occurs after the evoked gamma activity, creating an ‘aligned averaged’ response that 




Figure 1: An example of how data alignment can be used to improve analysis with 
simplified impulse signals that vary in time. The first trial within a set is used as an 
alignment setpoint for subsequent trials, which are shifted in time to line up with the 
setpoint. Averaging the aligned form of the signals produces a representative signal that 
resembles the constituent trials, whereas the unaligned averaged signal is significantly 
attenuated and visually distinct. 
 
This study proposes a novel method of analyzing the induced gamma activity of 
an averaged EEG response by using a method of data alignment, which may allow for a 
more accurate representation of the averaged induced gamma activity of a subject. EEG 
recordings were collected from ASD, ADHD, and TD/control children while performing 
a categorization task of faces depicting various emotions. These tasks have been 
frequently performed in the literature to record ToM and attention-based measures in 
control or TD subjects, and identify potential deficits in subjects with 
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neurodevelopmental disorders (Baron-Cohen, et al., 1997; Ribeiro & Fearon, 2010; 
Schulte-Rüther, Markowitsch, Fink, & Piefke, 2007).  
The gamma power of the responses was estimated by using a wavelet technique in 
MATLAB described in previous studies to isolate the gamma frequencies (Horrell et al., 
2010). Alignment was performed offline for each subject by selecting one waveform out 
of a set of analogous trials, and designating it as the setpoint for the subsequent trials. The 
Pearson-Product Moment correlation coefficient was used a similarity measure between 
the setpoint and subsequent trials, and was used to create an ‘averaged aligned’ waveform 
for each set. Gamma power was then calculated from both the aligned and unaligned 
waveforms. 
Our hypothesis was twofold. First, we anticipated that alignment would have a 
dramatic effect on reducing the attenuation observed in the averaged signal. By 
maximizing the Pearson-Product Moment correlation coefficient, we attempted to reduce 
the amount of destructive interference caused by the varying latencies during the 
averaging process, which was expected to reduce the attenuation, and increase the 
absolute induced gamma power. Second, we expected that the data alignment technique 
would allow us to better elucidate the induced gamma activity differences between 
ADHD, ASD, and control subjects. While it is possible that these differences may 
manifest themselves in the unaligned averaged waveforms, we anticipated that the 
alignment technique would emphasize these differences, and increase the statistical 
significance of the findings. This process may contribute to the analysis of induced 









II. SUBJECT RECRUITMENT AND DEMOGRAPHICS 
 Participants with ASD were recruited through the University of Louisville 
Weisskopf Child Evaluation Center (WCEC). Subject age ranged from nine to twenty 
years old. Diagnosis was made according to the Diagnostic and Statistical Manual of 
Mental Disorders (DSM-IV) (American Psychiatric Association, 2000) and was further 
confirmed with the Autism Diagnostic Interview – Revised (ADI-R) (Le Couteur, 2003). 
Each subject also had a medical evaluation performed by a developmental pediatrician. 
All subjects had normal hearing, which was confirmed by auditory tests conducted 
previously. Participants either possessed normal vision or wore corrective lenses. 
Subjects with a history of seizure disorder, significant hearing or visual impairment, any 
brain abnormality identified from imaging studies, or a diagnosed genetic disorder were 
excluded. All participants with autism were high-functioning persons with full scale IQ > 
80 assessed using the Wechsler Intelligence Scale for Children, Fourth Edition (WISC-
IV) (Wechsler, 2003) or the Wechsler Abbreviated Scale of Intelligence (WASI) 
(Wechsler, 2004). 
 The Structured Clinical Interview for DSM-IV (SCID-I/P) (First, 2002b) was 
used for diagnoses of ADHD. Nine subjects ranging from thirteen to twenty-one years 
old who currently meet DSM-IV-TR criteria for ADHD or attention-deficit disorder 
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(ADD) were included. Subjects were evaluated at the WCEC. Parents and teachers were 
asked to complete the Child Behavior Checklist or Teacher Report Form (Rescorla, 2001) 
to complete the diagnosis of ADHD. Parents were also interviewed using DSM-IV 
criteria for ADHD to further support the diagnosis. Only subjects with clinical features 
meeting criteria for ADHD in both the home and school setting, and also met DSM-IV 
criteria, were included. All ADHD participants had a medical history and a psychiatric 
evaluation. For children, both the parents and the child with ADHD provided information 
for the assessment. 
 Controls were recruited through advertisements in the local media. All control 
participants were free of neurological or significant medical disorders, had normal 
hearing and vision, and were free of psychiatric, learning, or developmental disorders 
based on self and parent reports. Subjects were screened for history of psychiatric or 
neurological diagnosis using the Structured Clinical Interview for DSM-IV Non-Patient 
Edition (SCID-NP) (First, 2002a). Participants within the control, ADHD, and autism 
groups were attempted to be matched by age, full scale IQ, and socioeconomic status of 
their family. Socioeconomic status of ASD, ADHD, and control groups was compared 
based on parent education and annual household income. Participants in each of the three 
groups had similar parent education levels.  
 Participating subjects and their parents or legal guardians were provided with full 
information about the study including the purpose, requirements, responsibilities, 
reimbursement, risks, benefits, alternatives, and role of the local Institutional Review 
Board (IRB). The consent and assent forms approved by the IRB were reviewed and 
explained to all subjects who expressed interest in participating in the study. All 
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questions posed by the subjects, parents, and legal guardians were answered before a 
consent signature was requested. If the individual agreed to participate, she/he signed and 
dated the consent form and received a copy cosigned by the investigator who obtained 
consent.  
 The mean age of 10 participants enrolled in the ASD group was 14.1 ± (standard 
deviation) 2.7 years (range 10-18 years, 8 males, 2 females), and the mean age of the 
ADHD group was 14.2 ± 3.9 years (N=9, range 10-19 years, 7 males, 2 females). The 
mean age of the Control (CNT) group (N= 11) was 14.8 ± 4.5 years (9-21 years, 8 males, 
3 females). The age difference between groups was not significant.  Six subjects from the 
ADHD group and six subjects from the ASD group were on medication. The children 
with ADHD were taking prescribed stimulants (Methylphenidate or 
Dextroamphetamine). Two children with ASD were also taking prescribed stimulants 
(Concerta, Adderall), and four were taking antidepressants (Fluoxetine, Sertraline) and 
mood stabilizers (Divalproex, Ariprazole). Two children in the ASD group had comorbid 
mild mood disorders and two had co-occurring anxiety disorders. One subject from the 
ADHD group had comorbid mild mood disorder, and one had anxiety disorder. These co-









III. DATA COLLECTION  
All EEG data used in this study was collected with a 128-channel Geodesics 
system (Net Station 200, v. 4.0) (Electrical Geodesics Inc. [EGI], OR), and was 
processed with a Macintosh G4 computer. EEG signals were sampled at 500 Hz during 
the categorization task and passed through an analog bandpass filter (0.1-200 Hz). A 
referential montage was used to standardize the EEG signals, with the reference point set 
as the vertex at position Cz. The Geodesic Sensor Net used was a lightweight, elastic 
structure housing silver/silver-chloride electrodes within a synthetic sponge on a pedestal. 
The sensor net was adjusted prior to the beginning of data collection to ensure that it fit 
the subject snugly, maximizing the contact made with the scalp, and minimizing the 
interference from nearby facial muscles (Figure 2). Sponges were soaked in potassium 
chloride prior to testing to promote electrode conductivity. Sensor impedance was 





Figure 2 - The 128-channel EEG sensor net and testing room used in this study. The net 
was adjusted to fit the scalp of each subject individually to ensure that the electrodes 
were appropriately placed. The subject was seated in front of a computer display where 
visual stimuli were presented for the categorization task. Note that the subject seen in this 
picture was not a participant of this study. 
 
Stimulus presentation for the gender/emotion recognition task was controlled via 
the E-prime software (Psychology Software Tools, Sharpsburg, PA) running on a 
personal computer. This software package is commonly used to design psychological 
experimental procedures using timed stimuli and signal recording. Facial images for the 
categorization task were presented on a fifteen inch flat-panel display. Subjects were 
seated during the study, and a chinrest was provided to keep the center of the display 
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approximately 50 cm from the subject’s eyes. Subject responses to the stimuli were 
collected via a keypad connected to the testing computer terminal (Serial Box, 
Psychology Software Tools, Sharpsburg, PA). Instructions varied between the four 
blocks of the study, and were presented on the screen to the subject prior to beginning a 
new segment of the test. All four segments required the subject to select one of two 
choices by pressing the corresponding button on the keypad explained in the instructions. 
 The experiment was divided into four segments, corresponding to four categories 
of facial images presented in the experiment: (1) gender recognition with neutral 
expressions, (2) gender recognition with emotional expressions, (3) anger versus disgust 
recognition, and (4) fear versus sadness recognition. The presentation of blocks in the 
study was counter-balanced to keep ordering effects negligible. In each section, the 
subject was asked to categorize the displayed face into one of two groups, differentiating 
either the gender or the perceived emotional state of the individual in the image. The 
subjects indicated their selection by pressing the corresponding button on the keypad. 
Each category contained sixty images for the subject to differentiate. Every image 
remained on the screen for a 300 ms period. Pauses between stimuli ranged from 1100-
1300 ms to avoid anticipatory effects. EEG recording occurred throughout the entire 
experimental procedure, but was later segmented into smaller data segments for more 
efficient analysis (Figure 3). The complete four category experiment took approximately 
twenty minutes to complete, including short breaks that were provided between image 








Figure 3 - A visual representation of the categorization task. Each image remained on the 
screen for 300 ms. The subject was given approximately 1100-1300 ms to categorize the 
face into one of two groups before the next image appeared on the screen. The time 
between images varied to discourage anticipation. Segmentation was performed for each 
image starting 200 ms before stimulus presentation, to 800 ms after stimulus presentation. 
 
 
 Each facial image category contained twenty-four unique black-and-white 
images, with equal representation of male and female subjects. Similarly, in emotion 
recognition tasks, each emotion was equally represented. The hair from all subjects in the 
images was removed to increase the difficulty of the categorization task. Seventy-two 
total images were used for all four categories, with some reuse between categories. All 
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images were randomly selected from standard databases of facial pictures developed for 
similar studies (Pictures of Facial Affect, Paul Ekman 1976-2004, Berkeley, CA; 
JACFEE/JACNeuF, David Matsumoto and Paul Ekman, 1988-2004, Berkeley CA). The 
subjects were required to complete sixty trials for each section corresponding to a 
different facial image category (Figure 4). 
 
 
Figure 4 - A representation of the four block experimental study and examples of the 
facial images used during the test procedure. Participants were asked to distinguish a face 
as belonging to one of two groups: male or female, angry or disgusted, or fearful or sad. 
Each test block consisted of sixty trials, with twenty-four unique images per trial. 
 
 The collected EEG recordings were stored in Net Station (EGI), tagged according 
to test category, and segmented offline into one second trials. The collected trials were 
first divided by subject type (ADHD, ASD, or control), and then kept separate for each 
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individual subject within that type. The data was then organized into four experimental 
conditions based on the task the subject was asked to perform: 1) Gender Recognition-
All, 2) Emotion Recognition-All, 3) Anger/Disgust Recognition, and 4) Fear/Sad 
Recognition (Figure 5). 11 of the 128 EEG channels were selected for induced gamma 
power analysis and further data processing (Figure 6). Approximately thirty trials were 
used for analysis in the Anger/Disgust and Fear/Sad recognition for each subject, and 
sixty trials were used in the Gender/Emotion Recognition. This data was exported into 
MATLAB for further signal processing. All subjects included in this study completed the 




Figure 5 - The four experimental categories used for data analysis. For each subject, sixty 
trials were selected for analysis in the gender and overall emotion recognition categories, 









































 After the collected EEG trials from the gender/emotion categorization task were 
organized as previously described, they were processed via Wavelet analysis. This 
technique allows for visualization of the collected signals in both the time and frequency 
domains, and can be used to isolate the frequencies of interest (i.e. the gamma band) from 
the broad spectra of EEG waveforms in combination with a digital filter. Wavelet 
analysis provides information about the dynamic changes in amplitude of gamma 
waveforms at varying frequencies within the selected time interval, as opposed to the 
static perspective offered by more traditional methods of Fourier analysis. In this study, a 
one-dimensional continuous wavelet transform (Equation 1) was performed using the 
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Equation 1: The general formula for the continuous Wavelet transform utilized in the 





 The Morlet window was selected as the mother wavelet ( ) in this analysis, a plot 
of which can be seen in Figure 7. The continuous wavelet transform created 128 
coefficients for each trial that underwent data analysis. The range of these coefficients 
contained information about the higher frequency (represented by lower coefficient 
numbers) and lower frequency (represented by higher coefficient number) components in 
the signal. 
 
Figure 7: A graphical representation of the Morlet window used in the continuous one-




 Following wavelet analysis, a custom bandpass filter with a Harris 7 window was 
applied to the signals to isolate frequencies of interest. This filter allowed for the passage 
of the gamma frequencies between 35-45 Hz with a two Hz attenuation band. The Harris 
window used in the filter design was composed of 725 samples. A similar Wavelet/Harris 
filtering technique was used in previous gamma analysis studies on neurofeedback and 
cue reactivity (Horrell et al., 2010). 
 
Data Alignment 
 Filtered data was further processed in MATLAB to create two datasets for 
analysis: one unaligned dataset (similar to what would be used in traditional EEG studies) 
to serve as a control, and another analogous dataset created after utilizing the proposed 
alignment technique on the segmented EEG trials. To construct the aligned dataset, 
segmented trials were organized into groups by subject, experimental condition, and EEG 
channel (i.e. thirty trials in group Eric-Anger/Disgust-P3, etc.). Within each group, the 
first trial was selected as the setpoint for that group to be used in the data alignment step. 
A 400 ms window from 200 to 600 ms post-stimulus was then segmented from the 
setpoint trial to capture the range of time where induced gamma activity is expected to 
occur. 
 Subsequent trials in the group were then compared to the setpoint. For each trial, a 
400 ms window starting at 100 ms post-stimulus was initially selected (i.e. 100 to 500 ms 
post-stimulus). The two-dimensional Pearson-Product Moment correlation coefficient 
(Equation 2) was then calculated between this window and the setpoint. The window was 
shifted by 2 ms forward in time (i.e. 102 to 502 ms post-stimulus) and the coefficient 
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calculation was repeated. This process was performed iteratively 101 times, shifting the 
window incrementally to cover a total time span of 100-700 ms post-stimulus in 400 ms 
segments. The 400 ms window with the largest positive correlation coefficient was then 
selected as the ‘aligned’ form of the signal, and was exported into the database for 
aligned trials. (Figure 8) This process was repeated for all signals within a group, and for 
all groups in the original dataset. 
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Equation 2: The formula to calculate the Pearson-Product Moment correlation 
coefficient, which was used to find the level of similarity between the setpoint and the 







Figure 8 - The step-by-step procedure of the alignment technique. First, the setpoint is 
chosen by segmenting the first signal in a set from 200-600 ms post-stimulus. Subsequent 
trials are then incrementally segmented in 400 ms pieces starting at 100 ms post-stimulus, 
with a 2 ms shift each increment. The correlation coefficient is calculated for each 
increment, and the level of shift that produces the highest positive coefficient value is 
selected as the ‘aligned’ 400 ms segment for analysis. This process is repeated for each 
trial within a set until each trial is aligned to the setpoint. 
 
 
 An unaligned database was also created by simply segmenting the original trials 
from 200 to 600 ms post-stimulus without utilizing any alignment technique. The 
unaligned segmented trials were organized into the same groups as the aligned dataset, so 






Averaging and Gamma Power Calculation 
 Trials within each group were averaged together in MATLAB to produce a 400 
ms signal for both the aligned and unaligned datasets. Gamma power was calculated by 
summing the squares of the amplitude at each point in the averaged signals. Gamma 
power was reported in units of μV
2
. A flowchart depicting the data analysis steps for the 
aligned dataset is shown in Figure 9. 
  
 
Figure 9 - A flowchart depicting the steps in the data analysis procedure for the aligned 
dataset. The unaligned dataset was created similarly, with the exclusion of the data 
alignment phase in the flowchart. 
 
 Power values from both datasets were organized into tables for statistical analysis. 
Within each subject type and experimental condition pairing (i.e. ADHD, Anger/Disgust, 
etc.) outliers were identified and removed using two standard deviations from the mean 
as the initial exclusion criteria. Subjects who had power values excluded for a particular 
EEG channel were retained in the study if other channels had values that were not 
excluded. If a power value for a particular subject, experimental condition, and channel 
(i.e. Eric-Anger/Disgust-P3, etc.) was excluded in the aligned dataset, the corresponding 
value was also excluded in the unaligned dataset, even if the unaligned value fell within 
two standard deviations of the mean for the unaligned pairing. Similarly, values excluded 

























 Data analysis was performed in SPSS (v. 18) and MINITAB (v. 16). Gamma 
power values calculated in the previous step were loaded into the program following the 
removal of outliers. A repeated measures analysis of variance (ANOVA) was performed 
with a combination of the following factors: experimental condition (Anger/Disgust, 
Fear/Sad, etc.), channel (P3, P4, etc.), hemisphere (right or left), alignment (aligned and 
unaligned) and in between subjects recruited for the study. Subjects were also split into 
subject groups (ADHD, ASD, or control) for some ANOVA models. Models were 
constructed to test for significant interactions between subject group, experimental 
condition, hemisphere, and alignment for channel pairs (i.e. P3 and P4, P7 and P8, etc.). 
Experimental conditions varied in our ANOVA models. Simple models compared the 
gender and emotion recognition tasks generally (i.e. Gender All vs. Emotion All) while 
more specific models looked at the individual emotion recognition tasks separately and 
compared them to the gender recognition task (i.e. Anger/Disgust vs. Gender All). 
Greenhouse-Geisser corrected p-values were used for determination of statistical 












Main Effect of  Data Alignment 
A significant main effect of alignment (F=995.89, p<0.0001) was observed across 
all parietal and occipital channels collected (P3, P4, P7, P8, P9, P10, POz, PO3, PO4, O1, 
O2). The significant main effects and interactions of the Anger/Disgust, Fear/Sad, 
Gender-All model are reported in Table I. This main effect of alignment was observed in 
all ANOVA models regardless of the experimental conditions selected for comparison. 
Similarly, the significant main effect for alignment was observed individually in all 
channels and hemispheric channel pairs. Line plots created in MINITAB depict the 
difference between averaged aligned and unaligned power values across subject and 









Figure 10 - Line plots emphasizing the difference between aligned and unaligned 
averaged power values across subject types (Left) and experimental conditions (Right). 
 
 A direct comparison of the aligned and unaligned signals was performed in 
MATLAB. Coinciding with the statistical analysis previously described, the amplitude of 
Factor       Type   Levels  Values
Condition    fixed       3  Anger-Disgust, Fear-Sad, Gender-All
Alignment    fixed       2  Aligned, Unaligned
Group        fixed       3  ADHD, Autism, Control
Analysis of Variance for Power-P, using Adjusted SS for Tests
Source                             DF   Seq SS   Adj SS   Adj MS       F      P
Condition                           2    11.41    11.52     5.76    3.45  0.032
Alignment                           1  1670.95  1663.13  1663.13  995.89  0.000
Group                               2    80.12    80.03    40.01   23.96  0.000
Condition*Alignment                 2     2.64     2.52     1.26    0.76  0.470
Condition*Group                     4     2.39     2.39     0.60    0.36  0.839
Alignment*Group                     2     0.98     1.04     0.52    0.31  0.733
Condition*Alignment*Group           4    17.91    17.91     4.48    2.68  0.030
Error                            1824  3046.07  3046.07     1.67
Total                            1841  4832.46
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the aligned waveforms appeared to be higher, resulting in greater overall power values 
for the aligned dataset. Two graphs prepared in MATLAB shown in Figure 11 provide an 
example of the difference between the aligned and unaligned waveforms for a single 
channel, subject, and experimental condition (i.e. P7-Eric-Anger/Disgust). 
 
Figure 11 - An example of aligned and unaligned EEG signals in parietal channels for a 




Additional Main Effects 
 Significant main effects for experimental condition (F=3.45, p=0.032) and subject 
group (F=23.96, p=0.000) were also present across all parietal and occipital channels in 
the Anger/Disgust, Fear/Sad and Gender-All ANOVA model, as reported in Table I. 






Figure 12 - A graph depicting the main effects of experimental condition and subject type 
across both the aligned and unaligned datasets. The emotional tasks were significantly 
higher in average mean induced gamma power for all subject types. Similarly, power 





 Significant Group-Condition-Alignment three-way interactions were observed 
generally across the parietal and occipital channels in the Anger/Disgust, Fear/Sad, 
Gender-All ANOVA model (F=2.68, p=0.030).  No significant two-way interactions 
were present across all channels when using this model. 
 In an ANOVA model that compared the Anger/Disgust recognition task to the 
gender recognition task, significant interactions could be seen in the P3-P4 channels 
(F=3.43, p=0.048) and P7-P8 channels (F=4.304, p=0.025). As shown in Figure 13, 
significant effects of Condition-Group pairings became more apparent in the aligned 
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datasets. Descriptive statistics for P3-P4 and P7-P8 three-way interaction groups are 




Figure 13 - Interaction plots for parietal channels depicting differences in Condition, 
Group, and Alignment pairings. Plots revealed significant interactions in the aligned 
dataset that would otherwise have gone unnoticed. Top: Channel pair P3-P4, Bottom: 





















ADHD Anger/Disgust 2.049 0.286 0.450 0.126
ADHD Gender All 1.354 0.203 0.315 0.084
Autism Anger/Disgust 1.292 0.283 0.320 0.126
Autism Gender All 1.360 0.203 0.143 0.084
Control Anger/Disgust 0.922 0.271 0.129 0.120
Control Gender All 0.943 0.192 0.072 0.080
ADHD Anger/Disgust 3.355 0.500 0.987 0.215
ADHD Gender All 2.798 0.491 0.620 0.160
Autism Anger/Disgust 2.031 0.530 0.333 0.228
Autism Gender All 2.769 0.520 0.172 0.169
Control Anger/Disgust 2.697 0.474 0.418 0.204











 This study attempted to answer two proposed questions: can the attenuation 
observed in the induced portion of collected gamma oscillations be reduced by using a 
method of data alignment, and can this method contribute to the analysis of differences 
between ASD, ADHD, and TD subjects? The obtained results contributed to answering 
both of these questions. The method of data alignment used in this study, while simple in 
its implementation, is novel in its application to power analysis of EEG signals. This 
study serves as a pilot investigation for future Theory of Mind influenced experiments 
comparing ASD, ADHD, and TD subjects. 
 
Main Effect of Alignment 
 Overall, the main effect of the alignment technique (p<0.0001) was the most 
profound in the entire study. With very few exceptions, the aligned averaged power of the 
induced gamma oscillations had a higher value than their unaligned counterpart. This 
effect is most notably observed in Figure 11 and Table I, and suggests that the data 
alignment technique employed in this study effectively reduces the attenuation of induced 




 The extremely large main effect of alignment may be explained by the nature of 
the MATLAB program utilized in this study. Our program aligned trials by shifting them 
within a fixed window of time to maximize the amount of overlap that occurs. This 
reduced the attenuation of the averaged signal. If the maximum overlap hypothetically 
occurred from trial to trial before performing any shift on the time axis, the ‘aligned’ 
dataset would be identical to the ‘unaligned’ dataset. Thus, the power of the aligned 
averaged waveform should always be equal to or greater than the power of the unaligned 
averaged waveform, since the program will not produce an aligned signal that is more 
attenuated than the unaligned signal. This effect was confirmed visually by examining the 
graphs of aligned and unaligned waveforms produced in MATLAB, as shown in Figure 
11. 
 The averaged induced gamma oscillations graphed in MATLAB Figure 11 verify 
the conclusions drawn from the statistical analysis, clearly showing that the aligned 
counterpart had a higher maximum amplitude on average, and consequently, a higher 
overall power value. This effect does not appear to be entirely random. The aligned 
oscillation for channel P8 in Figure shows that the amplitude of the aligned signal 
remains relatively close to that of the unaligned signal until approximately 400 ms post-
stimulus. At this point, the aligned oscillation quickly grows in amplitude for the 
remainder of the segment. This suggests that the alignment technique used in this study 
does not artificially increase the amplitude at all points. If the induced gamma activity is 
only active during a particular window of the total time, then the aligned averaged 
oscillation produced will reflect that phenomena. Thus, the aligned averaged response 
appears to remain true to the behavior of the constituent signals. 
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Other Main Effects 
 Although the focus of this study was on the effect of alignment, and how the 
technique may further understanding in the study of ADHD, ASD, and TD subjects, the 
experimental condition and subject group main effects are important to note. Had these 
effects appeared insignificant in the statistical analysis, the justification for using data 
alignment in these particular kinds of experiments would be significantly weakened. 
Detection of differences in the performance of subjects across different experimental 
conditions and subject groups verifies that this study is working with meaningful metrics, 
and coincides with expectations in the literature. 
 The main effect of experimental condition (p=0.032), as reported in Table I, 
suggests that the type of recognition task the subject was asked to perform had an effect 
on the induced gamma power recorded on average, regardless of the alignment method 
used, channel selected, or subject group observed. As shown in Figure 10, the emotion 
recognition tasks (i.e. Anger/Disgust, Fear/Sad) appeared to produce higher power levels 
on average than the gender recognition tasks. This coincides with the original hypothesis 
that suggested that the emotional recognition tasks would be more intensive than the 
simpler, gender recognition task. 
 Similarly, the main effect of subject group (p<0.01) reported in Table 1 suggests 
that the different types of subjects (i.e. ADHD, ASD, and TD) performed differently in 
the various tasks. This effect may also be observed in Figure 10, which suggests that the 
induced gamma power was higher in individuals with ADHD or ASD on average, across 
all channels, experimental conditions, and alignment methods. Because it is expected that 
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children with neurodevelopmental disorders will struggle with these recognition tasks 
more than TD children, this result seems reasonable. 
 
Significant Interactions 
 Significant Group-Condition-Alignment three-way interactions seen in the 
parietal channels suggest that the alignment procedure produces data that better resolves 
the differences between Group-Condition pairings. Whereas significant Group-Condition 
effects would have gone unnoticed in the parietal channels with traditional techniques, 
alignment provided a means of visualizing these significant differences between ADHD, 
ASD and control subjects. This effect was observed across all parietal and occipital 
channels using the Anger/Disgust, Fear/Sad, Gender-All ANOVA model, as observed in 
Figure 12 and Table I, and in individual parietal channel pairings using the Anger/Disgust 
and Gender-All ANOVA model as shown in Figure 13 and Table II. 
 Multiple ANOVA models were used to identify the situations where the most 
significant results were produced. Although a general three-way significant interaction 
was observed using the Anger/Disgust, Fear/Sad, Gender-All ANOVA model across all 
parietal and occipital channels, the same effect was only observed in individual channel 
pairings (i.e. P3 and P4, P7 and P8) when the ANOVA model was changed to 
Anger/Disgust and Gender-All only. It is hypothesized that the Anger/Disgust task may 
produce the strongest emotional response during the study, effecting the highest induced 
power levels. Thus, by limiting the statistical analysis to the Anger/Disgust recognition 
task and the less difficult gender-recognition task, more significant interactions were 
observed when looking at the individual channel pairings. This simplified ANOVA 
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model still provides useful information, because it compares an emotional recognition 
task to the gender recognition task across the various subject types and experimental 
conditions. 
 
Comparison of Induced Gamma Power in Subject Groups 
 Prior to analysis, it was hypothesized that the emotion recognition tasks would be 
more challenging for ADHD and ASD subjects than the gender recognition tasks, and 
would be more likely to effect changes in the induced gamma waveforms between the 
subject groups. The significant interactions in Figure 13 reveal some trends that support 
this hypothesis. Within the aligned datasets, the power of the gender recognition task 
remained relatively constant between ASD, ADHD, and control subjects. Much greater 
variation is seen in the anger/disgust recognition task. ADHD subjects typically exhibited 
a higher induced gamma power during this task compared to the gender recognition task. 
Conversely, ASD subjects had a lower induced gamma in the anger/disgust recognition 
task versus the gender recognition task. Control subjects had relatively small differences 
between the induced power of the two tasks compared to ADHD (P3-P4 and P7-P8) and 
ASD (P7-P8) subjects. 
 Although these effects were not observed in other channel pairings, their effect 
was strong enough to cause the three-way interaction to be present in the statistical 
analysis of all of the parietal and occipital channels, as shown in Table 1. It is possible 
there was an insufficient amount of subjects or data samples in this study to reveal the 
significant three-way interaction in all channel pairings. It is also possible that this 
interaction may be limited to the parietal region covered by channels P3, P4, P7, P8. 
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 The parietal/occipital channels are of particular interest and were chosen for 
analysis because of their involvement with mentalizing and visual processes, and their 
proximity to the temporal region, where the fusiform face area is located. These regions 
are hypothesized to be connected to facial recognition mechanisms, and are the subjects 
of study in Theory of Mind research, particularly those studies that involve subjects with 
ASD. 
 This study is merely a pilot for future research into the induced gamma behavior 
of ASD, ADHD, and TD subjects during facial categorization and other ToM tasks. The 
statistical analysis demonstrated that the alignment method used identified interactions 
between subject groups and experimental conditions that would otherwise have gone 
unnoticed, and these differences coincide with expectations from the literature. Further 
investigation would be necessary to draw more rigorous conclusions from this type of 
study. 
 
Data Processing Method 
 The outlined alignment procedure may be modified for future studies. A wide 400 
ms window was selected to ensure that the induced gamma region of the signals was 
captured, though this window could be changed to any value less than the total length of 
the signal. Similarly, the selection of the setpoint window from 200 to 600 ms post-
stimulus could be shifted if the induced gamma is anticipated to occur at a different point 
in time. The incremental comparisons between the setpoint and subsequent trials in a 
group were made every 2 ms based on the system sampling frequency of 500 Hz, though 
this value could be increased to improve the speed of the program at the cost of lower 
40 
 
resolution. The time range examined in the incremental comparisons was set from 100 to 
700 ms post-stimulus, but this range may be changed as needed.  
A potential source of error this alignment technique introduces is the selection of 
a setpoint. In this study, the first trial in each Subject-Condition-Channel group was 
segmented from 200-600 ms, and used to align the subsequent trials in the group. If this 
trial had artifacts or grossly abnormal induced gamma activity, it is possible that the 
system may align the subsequent trials improperly. This may be alleviated by examining 
trials prior to analysis, as was done in this study. Future efforts may include incorporating 
an algorithm that examines the setpoint prior to alignment, and accepts or rejects it based 
on user-contributed criteria (i.e. amplitude threshold, minimum power, etc.).  
An additional source of potential error in this study is the selection of EEG 
channels for analysis. Although the selected electrodes are organized into a standardized 
system to allow for some universal comparison, only ten of the 128 recording electrodes 
were analyzed. Many of these electrodes were in regions of no interest in this study (i.e. 
frontal, etc.) but other parietal/occipital electrodes could have been selected, that may 










VII. FUTURE WORK 
A potential modification to the data alignment technique involving peak detection 
was investigated during this study, but would require further refinement before it could 
be implemented for use. In brief, the MATLAB program would be designed to identify 
the region within the segmented trials with the highest amplitude (presumably where the 
peak of the induced gamma oscillations were occurring) and would take a power reading 
over a small window centered at that point. This could potentially eliminate the iterative 
process used in this study to align the signals to one another, which would reduce the 
time required to run the program. A future study could be performed comparing this 
alignment method to the correlation coefficient method proposed in this study. 
Although the parietal and occipital channels were the subject of interest in this 
study, the same analysis could be applied to the frontal channels, where higher cognitive 
activities may be involved in the processing of the recognition tasks. As previously 
mentioned, the parameters of the data alignment process may be freely changed prior to 
analysis. If differences in the induced gamma behavior distinguished the frontal EEG 
channels from the parietal/occipital channels (i.e. window of activity), it would simply be 
a matter of identifying that behavior prior to analysis, and modifying the alignment 
procedure to compensate for those differences. 
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This study compared differences between ADHD, ASD, and control subjects, but 
this same technique could be employed for other conditions, such as Parkinson’s disease, 
Alzheimer’s disease, post-traumatic stress disorder, and addiction disorders. Any 
condition where a visual, emotional, or attentional task may evoke unusual responses 
could serve as a potential candidate for further study via induced gamma waveform 
analysis. Similarly, the frequency band of interest may be modified simply by changing 
the Wavelet/Bandpass filter. Though 30-45 Hz is typically the region of interest for 
induced gamma studies, it is possible to expand the filter to include the higher gamma 
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APPENDIX I – MATLAB ALIGNMENT CODE 
%========================================================================== 
% Alignment Code 








% ===== Read all of the trials ============================================ 
parentDir=cd; 
allData_dir =[cd '\Aligned\Post-Gamma\']; 
% Output directory to save results 
OutDir = [cd '\Aligned\Aligned Post-Gamma\']; 
  
dataFolders = dir(allData_dir); 
% Total # of subjects (Includes hidden folders) 
FL = length(dataFolders);       
  
Ks=0; 
for zz =1 : FL 
    % Takes care of hidden files. 
    if strcmp(dataFolders(zz).name,'.') | strcmp(dataFolders(zz).name,'..') 
        continue; 
    end 
    Ks=Ks+1; 
end 
  
% This loops is for all patient groups (i.e. ASD, ADHD, etc.) 
typeCount =0; 
for yy = 1 : FL    
    yy; 
    % Takes care of hidden files. 
    if strcmp(dataFolders(yy).name,'.') | strcmp(dataFolders(yy).name,'..') 
        continue; 
    end 
     
    typeCount = typeCount+1; 
    % Current Data Set Directory and its Output Directory 
    curFolder = dataFolders(yy).name; 
    curData_dir=[allData_dir, curFolder ]; 
    mkdir(OutDir, curFolder) 
    curData_out=[OutDir,curFolder ]; 
     
    %====================================================================== 
    %====================================================================== 
     
    patientFolders = dir(curData_dir); 
    % Total # of subjects within a patient group (Includes hidden folders) 
    FL2 = length(patientFolders);       
     
    Ks2=0; 
    for vv =1 : FL2 
        % Takes care of hidden files. 
        if strcmp(patientFolders(vv).name,'.') | 
strcmp(patientFolders(vv).name,'..') 
            continue; 
        end 
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        Ks2=Ks2+1; 
    end 
     
    %This loop is over all patients within a specific type (i.e. ADHD). 
    patientCount = 0; 
    for yy2 = 1 : FL2    
          yy2; 
    % Takes care of hidden files. 
    if strcmp(patientFolders(yy2).name,'.') | 
strcmp(patientFolders(yy2).name,'..') 
        continue; 
    end 
     
    patientCount = patientCount+1; 
    % Current Data Set Directory and its Output Directory 
    patientFolder = patientFolders(yy2).name; 
    patientData_dir=[curData_dir,'\' patientFolder ]; 
    mkdir(curData_out, patientFolder) 
    patientData_out=[curData_out,'\' patientFolder ]; 
     
    %=================================================================== 
    %=================================================================== 
         
    conditionFolders = dir(patientData_dir); 
    % Total # of experimental conditions (i.e. Anger/Disgusted) (Includes 
hidden folders) 
    FL3 = length(conditionFolders);       
         
    Ks3=0; 
    for cc =1 : FL3 
         % Takes care of hidden files. 
         if strcmp(conditionFolders(cc).name,'.') | 
strcmp(conditionFolders(cc).name,'..') 
                continue; 
            end 
            Ks3=Ks3+1; 
        end 
         
       %This loop is over all conditions (i.e. Anger/Disgust) for a certain 
subject. 
       condCount = 0; 
        
       for yy3 = 1 : FL3    
            % Takes care of hidden files. 
            if strcmp(conditionFolders(yy3).name,'.') | 
strcmp(conditionFolders(yy3).name,'..') 
                continue; 
            end 
            condCount = condCount+1; 
            % Current Data Set Directory and its Output Directory 
            condFolder = conditionFolders(yy3).name; 
            conditionData_dir=[patientData_dir,'\' condFolder ]; 
            mkdir(patientData_out, condFolder) 
            curCondition_out=[patientData_out, '\' condFolder ]; 
              
  
xlsDir_Input = conditionData_dir 
cd(xlsDir_Input)      % Input data folder 
%xlsDir_Output=[cd '\Output_Excel_Files\'];     % Output data folder 
  
%Structure with all files in the specified dir. 
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allXls_Files = dir(xlsDir_Input);  
%Total # of files inncludes hidden ones 
FL = length(allXls_Files);         
  
conditionFiles = dir(conditionData_dir); 
% Total # of subjects (Includes hidden folders) 
FL4 = length(conditionFiles);       
             
 Ks4=0; 
for ff =1 : FL4 
% Takes care of hidden files. 
   if strcmp(conditionFiles(ff).name,'.') | 
strcmp(conditionFiles(ff).name,'..') 
      continue; 
   end 





% Outlines the alignment parameters 
% corrStep = The shift on the x-axis between trials that are being compared t 
%            to the setpoint. 
% startStep = The furthest, left-most starting point for the alignment  
%             process to begin. 
% endStep = The furthest, right-most ending point for the alignment process 
%           to conclude on. 
  
Sxls_all=['A' num2str(1) ':R' num2str(201)]; 
corrStep = 1; 
startStep = -50; 
endStep  = 50; 
fileCount = 0; 
  
%========================================================================== 
% This portion identifies the setpoint for a particular patient and 
% experimental condition. All eighteen channels are independently and 
% simultaneously aligned. 
  
            for yy4 = 1 : FL4   %To pick up the first trial 
                % Takes care of hidden files. 
                if strcmp(conditionFiles(yy4).name,'.') | 
strcmp(conditionFiles(yy4).name,'..') 
                    continue; 
                end 
                fileCount = fileCount+1; 
                % Current Data Set Directory and its Output Directory 
                condFile = conditionFiles(yy4).name; 
                allChannelsRef = xlsread([conditionData_dir, '\' condFile ]); 
                selChannelsRef =zeros(size(allChannelsRef,1),18); 
                 
                for  k =1:18 
                    selChannelsRef(:,k) = allChannelsRef(:,k); 
                end 
                 
                croopedChannelsRef = selChannelsRef(200:400,:); 
                break 
            end 






% This portion aligns the remaining trials within each patient-condition 
% folder. The channels are independetly aligned (i.e. F1 might be shifed 
% 30 ms backward, while F2 is shifted 80 ms forward). The startStep and 
% endStep represent the range on the x-axis that the program will attempt 
% to align the trials. The corrStep is the resolution of the alignment 
% process. 
             
            for yy4 = 4 : FL4   %This loop starts from the second trial 
                % Takes care of hidden files. 
                if strcmp(conditionFiles(yy4).name,'.') | 
strcmp(conditionFiles(yy4).name,'..') 
                    continue; 
                end 
                 
                % Current Data Set Directory and its Output Directory 
                condFile = conditionFiles(yy4).name; 
                allChannels = xlsread([conditionData_dir, '\' condFile ]); 
                selChannels =zeros(size(allChannels,1),18); 
                 
                for  k =1:18 
                    selChannels(:,k) = allChannels(:,k); 
                end 
                 
                allCorr_vals = zeros(endStep-startStep+1,18); 
                myCount =0; 
                 
                candChannels = zeros(size(croopedChannelsRef,1),18); 
                for ee =1:18 
                    myCount =0; 
                    Corr_vals = zeros(endStep-startStep+1,1); 
                    for hh = startStep:corrStep:endStep 
                        myCount = myCount+1; 
                        croopedChannels = selChannels(200+hh:400+hh,:); 
                        Corr_vals(myCount) 
=(corr2(croopedChannelsRef(:,ee),croopedChannels(:,ee))); 
                    end 
                    [curVal curPos]=max(Corr_vals); 
                    candChannels(:,ee) = 
selChannels(200+startStep+curPos:400+startStep+curPos,ee); 
                    allCorr_vals(:,ee) =Corr_vals; 
                end 
                xlswrite([ curCondition_out '\' condFile 
],candChannels,Sxls_all) 
                 
            end 
        end 







APPENDIX II – DATA TABLES 
TABLE III – INDUCED GAMMA POWER TABLE 
 
  
20 4 25 124 34 122 11 53 87 59 92 68 60 86 58 97 72 77
F1_AD F2_AD F3_AD F4_AD F7_AD F8_AD Fz_AD P3_AD P4_AD P7_AD P8_AD POz_AD PO3_AD PO4_AD P9_AD P10_AD O1_AD O2_AD
AD_1' ADHD 1.619 1.898 1.463 2.205 2.455 3.935 2.076 0.638 0.986 2.094 1.668 1.823 1.643 2.409 2.099 2.448 2.862 2.998
AD_2' ADHD 0.755 0.975 1.867 1.147 3.061 0.771 1.092 2.324 1.795 3.736 4.787 2.602 3.748 3.053 4.090 2.849 6.195 5.921
AD_3' ADHD 3.356 1.922 2.442 1.832 2.212 3.026 3.122 0.093 0.342 0.391 1.662 0.352 0.985 0.392 0.376 1.240 0.393 0.327
AD_4' ADHD 1.238 2.575 2.762 1.544 1.412 1.385 5.898 5.623 3.282 2.457 4.266 5.976 4.680
AD_5' ADHD 0.443 2.323 0.803 2.116 1.666 2.480 0.205 1.858 6.800 2.449 4.910 2.751 2.429 1.436 2.435 2.494 5.856 6.377
AD_6' ADHD 1.564 2.246 1.804 3.115 2.997 1.617 2.807 1.480 2.070 1.631 2.332 4.873 5.236 1.805 1.568 2.616 2.460
AD_7' ADHD 3.033 4.091 2.118 1.983 1.620 4.756 3.032 6.575 5.341 3.116 4.866 3.037 4.214 4.688
AD_8' ADHD 1.315 1.861 1.593 1.739 2.007 2.387 1.957 2.571 2.856 1.856 4.401 0.766 1.800 1.421 2.046 4.465 0.506 1.010
AD_9' ADHD 2.641 2.867 2.549 1.859 2.337 0.970 2.195 5.154 2.458 5.237 4.051 2.786 4.212 2.712 4.225 3.124
AS_1' Autism 1.578 2.522 1.357 4.485 1.349 1.355 4.086 2.567 1.266 3.407
AS_2' Autism 1.468 1.324 1.048 1.168 1.800 1.843 1.340 0.788 1.144 2.312 0.931 0.442 1.063 2.638 1.435 0.855 1.355 1.291
AS_3' Autism 0.980 0.065 1.203 0.499 1.228 1.920 0.786 1.053 0.187 1.850 1.979 0.235 1.174 1.301 2.931 1.236 2.697 4.139
AS_4' Autism 7.002 5.736 6.608 5.301 6.075 0.593 0.106 0.520 0.139 0.380 0.566 1.143 0.578 0.435 0.375 0.319
AS_5' Autism 2.235 2.555 1.940 2.728 3.103 2.945 3.692 2.524 1.677 2.960 2.251 3.933 3.199 2.596
AS_6' Autism 1.383 2.673 2.765 6.538 1.857 1.578 2.364 3.076 3.190 1.145 3.404 3.956 5.576 3.134 4.018 5.869
AS_7' Autism 2.059 3.782 4.719 3.668 3.710 3.690 3.431 2.303 3.836 3.020 6.807 6.292
AS_8' Autism 2.614 3.037 3.154 3.868 6.191 2.246 1.092 0.461 1.292 1.937 0.865 1.523 1.426 1.246 2.057 0.921 1.166
AS_9' Autism 0.623 1.047 0.925 1.165 0.844 1.159 1.128 1.058 0.635 2.341 0.992 2.954 2.370 0.966 1.071 0.954 3.435 3.528
AS_10' Autism 1.208 0.865 1.323 1.104 3.253 5.675 1.307 3.088 0.807 3.012 3.089 4.192 4.084 1.318 3.037 1.830 5.100 6.219
C_1' Control 0.411 0.317 0.563 2.715 2.980 0.049 1.022 1.976 7.562 3.250 5.550 7.162 2.050 6.749 3.775
C_2' Control 0.519 0.418 2.832 2.095 4.053 0.885 0.821 1.958 2.710 1.736 2.630 3.717 3.326 4.658 3.568
C_3' Control 1.224 2.783 1.403 4.541 1.409 1.045 0.279 0.278 0.354 2.360 0.102 0.259 2.801 0.392 2.671 0.245 0.121
C_4' Control 1.116 1.283 1.694 1.619 1.956 2.812 0.904 0.802 1.168 2.835 1.646 1.118 1.369 3.333 2.733 4.320 3.403 3.923
C_5' Control 0.934 1.090 0.875 1.631 1.022 1.840 1.608 0.482 1.389 1.301 2.527 2.333 1.073 2.037 1.414 3.176 1.936 2.191
C_6' Control 1.175 1.558 1.184 1.972 4.148 4.331 1.316 1.626 1.647 3.189 4.978 2.522 2.641 2.082 2.079 1.895 6.849 7.098
C_7' Control 0.775 1.476 0.919 4.543 1.291 0.976 0.545 0.601 0.495 2.307 0.186 0.509 0.196 0.777 2.423 0.371 0.237
C_8' Control 3.010 1.341 3.182 1.315 3.452 4.774 1.153 1.060 0.318 0.749 1.357 0.342 0.776 0.447 0.916 5.033 0.648 0.619
C_9' Control 2.303 4.234 3.669 4.223 4.862 2.376 1.509 0.029 2.225 2.506 0.776 2.217 0.028 3.532 1.026 1.195
C_10' Control 2.149 0.686 1.696 0.818 4.165 4.048 2.822 0.357 0.576 0.745 1.775 0.046 0.403 0.582 1.371 2.632 0.846 0.777
C_11' Control 2.722 3.348 3.005 3.264 4.399 4.878 3.658 5.951 3.882 7.471 4.314 6.576 3.692 6.796
20 4 25 124 34 122 11 53 87 59 92 68 60 86 58 97 72 77
F1_EM F2_EM F3_EM F4_EM F7_EM F8_EM Fz_EM P3_EM P4_EM P7_EM P8_EM POz_EM PO3_EM PO4_EM P9_EM P10_EM O1_EM O2_EM
AD_1' ADHD 1.634 1.895 1.529 2.080 2.788 3.333 1.930 0.699 1.290 1.941 2.026 1.732 1.533 2.957 2.063 2.270 2.868 3.213
AD_2' ADHD 0.585 1.079 1.378 1.242 1.728 0.726 1.095 2.181 0.958 3.544 3.251 2.870 3.632 1.772 4.106 2.011 4.969
AD_3' ADHD 2.825 2.148 2.479 2.312 2.044 4.258 4.248 0.146 0.346 0.474 1.597 0.424 1.091 0.344 0.566 1.190 0.434 0.373
AD_4' ADHD 1.083 1.113 2.005 4.567 1.020 1.579 1.373 4.261 4.851 2.391 2.013 4.070 4.813 5.914 3.594
AD_5' ADHD 0.458 1.997 0.696 1.730 1.640 2.413 0.223 2.080 3.658 2.644 4.510 2.030 2.482 1.286 1.963 2.681 4.969 5.263
AD_6' ADHD 1.668 2.225 1.960 3.669 3.247 5.172 1.680 2.607 2.020 2.121 2.230 2.576 5.007 5.511 2.397 2.021 2.945 4.014
AD_7' ADHD 2.769 3.549 4.085 1.703 3.990 1.686 1.425 3.672 2.830 4.759 4.446 2.691 4.281 2.836 3.406 3.743
AD_8' ADHD 1.454 2.080 1.471 2.159 1.885 3.696 1.830 2.171 1.644 1.167 4.445 0.537 1.431 1.227 1.323 4.585 0.352 0.979
AD_9' ADHD 2.267 2.870 2.464 2.257 2.405 1.591 2.791 2.405 4.216 4.401 3.648 3.940 2.469 4.439 3.525
AS_1' Autism 0.897 1.620 1.071 3.008 0.901 1.031 2.495 2.578 0.893 1.515
AS_2' Autism 1.500 1.298 1.127 1.030 2.121 1.854 1.487 1.626 1.171 3.020 1.570 0.844 2.614 3.061 2.186 0.906 1.917 1.384
AS_3' Autism 0.901 0.095 1.224 0.819 1.503 2.437 0.837 0.956 0.217 1.944 2.238 0.282 1.113 1.470 2.380 1.528 2.384 3.594
AS_4' Autism 4.158 4.153 4.345 2.503 4.179 0.426 0.074 0.357 0.101 0.211 0.428 1.531 0.391 0.255 0.269 0.161
AS_5' Autism 3.746 3.715 2.074 2.769 3.697 3.759 3.492 1.716 1.604 4.784 3.661 2.246 3.141 2.950 4.965 1.732 4.898
AS_6' Autism 1.088 2.586 2.114 4.258 1.896 1.404 2.731 3.194 3.612 1.350 3.921 4.030 6.005 3.400 4.298 6.419
AS_7' Autism 0.921 2.005 2.983 3.161 4.606 5.143 3.210 4.462 7.244
AS_8' Autism 3.245 2.926 3.330 4.221 2.282 1.198 0.567 1.757 2.239 2.185 2.433 1.566 1.776 3.234 1.896 1.766
AS_9' Autism 0.505 1.059 0.788 1.169 0.798 1.143 1.086 1.117 0.738 2.437 1.170 3.173 2.511 1.122 1.084 1.126 3.206 3.430
AS_10' Autism 1.345 0.856 1.473 1.073 2.676 3.698 1.222 3.402 0.955 3.816 4.474 6.901 1.674 3.876 2.659 4.052 5.920
C_1' Control 0.445 0.296 0.672 2.463 2.447 0.050 1.043 1.906 7.804 3.293 5.731 6.380 1.991 7.290 3.258
C_2' Control 0.510 0.311 3.326 1.928 5.706 3.238 0.670 0.855 1.703 3.193 1.759 3.156 3.796 3.616 5.416 3.729
C_3' Control 1.328 1.976 1.400 2.970 1.447 1.059 0.391 0.329 0.440 2.756 0.149 0.408 2.841 0.511 2.862 0.374 0.173
C_4' Control 1.036 1.292 1.563 1.575 1.734 2.734 0.895 1.329 1.059 2.541 1.600 1.093 1.244 3.343 2.576 3.537 3.468 3.928
C_5' Control 0.946 1.096 0.824 1.675 1.103 1.782 1.664 0.568 0.859 1.335 2.528 2.373 1.134 2.191 1.457 3.034 2.043 2.188
C_6' Control 1.439 1.461 1.395 2.519 3.362 4.362 1.215 1.564 2.249 7.341 5.057 1.760 3.223 2.060 2.438 1.917 3.695 6.052
C_7' Control 0.666 1.190 0.908 3.501 1.273 5.612 0.835 0.545 0.487 0.490 1.367 0.184 0.516 0.224 0.877 1.619 0.491 0.416
C_8' Control 1.636 1.509 6.451 1.836 1.418 0.417 1.386 1.645 0.502 1.437 0.735 1.030 6.311 1.069 1.175
C_9' Control 2.553 4.832 4.191 4.794 5.388 2.684 1.577 0.028 2.331 2.331 0.808 2.316 0.025 6.866 3.440 1.043 1.217
C_10' Control 1.404 0.633 1.144 0.775 2.748 3.315 2.178 0.427 0.545 0.738 1.732 0.060 0.474 0.588 1.648 2.741 0.901 0.747





TABLE III (continued) 
 
  
20 4 25 124 34 122 11 53 87 59 92 68 60 86 58 97 72 77
F1_FS F2_FS F3_FS F4_FS F7_FS F8_FS Fz_FS P3_FS P4_FS P7_FS P8_FS POz_FS PO3_FS PO4_FS P9_FS P10_FS O1_FS O2_FS
AD_1' ADHD 1.443 1.756 1.502 2.302 2.120 3.091 1.633 0.769 1.740 2.078 2.600 1.763 1.541 2.739 2.488 3.225 4.375 4.210
AD_2' ADHD 0.549 1.161 1.003 1.318 1.109 0.828 1.174 2.043 0.368 3.384 2.021 1.981 3.487 1.109 3.874 1.541 5.032 3.564
AD_3' ADHD 3.343 2.358 2.430 2.321 2.016 4.128 4.796 0.142 0.377 0.556 1.560 0.469 1.306 0.360 0.574 1.110 0.472 0.401
AD_4' ADHD 1.000 1.193 2.203 1.150 1.475 1.460 4.366 2.987 1.876 4.435 4.993 3.839
AD_5' ADHD 0.476 1.763 0.601 1.511 1.704 2.291 0.209 1.574 1.878 2.309 4.882 1.718 2.259 1.210 2.101 3.370 5.378 5.669
AD_6' ADHD 1.455 2.981 2.289 4.414 3.873 2.634 1.459 1.941 2.581 2.357 2.227 1.593 4.960 5.142 3.419 1.821 2.682 2.738
AD_7' ADHD 2.494 5.375 3.716 1.763 4.182 1.466 1.563 3.309 3.689 4.394 3.493 3.687 4.805 3.925 6.110 3.663 3.755
AD_8' ADHD 1.413 2.458 1.448 2.579 2.060 3.986 2.025 1.811 1.409 0.927 4.550 0.570 1.254 1.071 1.154 4.757 0.367 0.988
AD_9' ADHD 2.745 3.004 2.740 2.516 2.187 1.542 2.261 2.073 2.956 3.037 3.370 4.524 1.956 3.368 3.139
AS_1' Autism 0.988 1.631 1.241 2.999 0.989 1.181 2.287 2.763 0.999 1.433
AS_2' Autism 1.648 1.540 1.343 1.196 2.482 2.051 1.936 2.460 1.123 3.988 1.722 1.177 4.704 3.531 2.203 1.128 2.457 1.529
AS_3' Autism 0.859 0.097 1.014 0.878 1.557 2.233 1.004 0.695 0.212 1.813 2.378 0.250 1.098 1.537 2.364 1.641 2.183 3.618
AS_4' Autism 3.954 4.325 4.018 6.188 2.173 4.029 0.483 0.059 0.333 0.092 0.270 0.465 1.881 0.376 0.257 0.301 0.164
AS_5' Autism 5.718 4.793 2.197 2.789 4.941 3.852 3.838 1.854 2.335 4.641 4.419 3.087 3.062 3.247 4.888 1.687 5.127
AS_6' Autism 1.131 2.719 2.166 3.405 2.157 1.548 3.180 3.245 4.305 1.435 4.412 4.638 6.991 3.903 4.883 6.748
AS_7' Autism 0.921 2.005 2.983 3.161 4.606 5.143 3.210 4.462 8.378 8.076 7.244
AS_8' Autism 3.067 2.920 3.972 4.446 6.872 2.527 1.668 0.491 1.761 3.817 1.823 2.889 1.024 2.144 4.962 2.012 1.416
AS_9' Autism 0.539 1.441 0.739 1.657 1.126 1.578 1.143 1.347 0.933 2.053 1.246 3.200 1.975 1.176 1.127 1.960 2.320 2.680
AS_10' Autism 1.358 0.966 1.620 1.157 2.960 3.813 1.346 4.068 1.078 3.931 5.291 1.820 3.818 2.793 4.228 5.979
C_1' Control 0.742 0.292 0.988 6.332 2.031 1.927 0.046 1.379 1.599 3.559 6.942 6.810 1.751 7.564 3.804
C_2' Control 0.497 0.316 3.827 1.896 4.655 3.400 0.684 0.898 1.751 3.129 1.853 3.077 4.067 4.040 6.120 3.926
C_3' Control 1.775 2.052 1.837 3.443 1.796 7.002 1.417 0.554 0.412 0.671 2.682 0.223 0.579 3.764 0.705 2.823 0.510 0.241
C_4' Control 1.041 1.200 1.430 1.186 1.512 2.255 0.949 2.161 0.926 2.581 1.566 1.394 1.156 3.331 2.544 3.913 3.097 3.390
C_5' Control 0.726 1.796 0.861 2.080 1.315 2.039 1.376 0.857 0.598 1.339 2.151 2.186 1.130 2.539 1.447 1.828 2.055 2.284
C_6' Control 2.117 1.874 1.665 3.004 4.525 5.648 1.663 1.787 2.110 6.170 1.438 2.875 2.221 2.767 1.931 2.625 4.925
C_7' Control 0.598 0.971 0.804 2.172 1.442 3.492 0.727 0.601 0.760 0.694 1.046 0.195 0.642 0.241 0.894 1.242 0.835 0.756
C_8' Control 1.556 1.549 2.187 1.355 0.425 1.405 1.680 0.539 1.401 0.785 0.947 6.782 1.155 1.249
C_9' Control 2.617 4.559 3.874 4.715 4.629 2.802 1.652 0.023 2.677 2.193 0.883 2.481 0.024 6.054 3.173 1.215 1.392
C_10' Control 1.306 0.581 1.124 0.695 2.480 3.043 2.052 0.452 0.566 0.807 1.500 0.067 0.491 0.587 1.841 2.387 0.878 0.746
C_11' Control 2.593 3.250 3.865 2.750 4.459 3.650 4.489 6.041 5.679 6.842 4.247 7.509 7.124
20 4 25 124 34 122 11 53 87 59 92 68 60 86 58 97 72 77
F1_GE F2_GE F3_GE F4_GE F7_GE F8_GE Fz_GE P3_GE P4_GE P7_GE P8_GE POz_GE PO3_GE PO4_GE P9_GE P10_GE O1_GE O2_GE
AD_1' ADHD 2.049 2.210 2.179 2.857 2.241 3.075 1.889 0.779 1.752 2.882 2.661 2.129 1.780 4.052 3.788 4.472 5.452 5.708
AD_2' ADHD 0.641 0.786 0.992 0.885 1.427 0.680 0.719 1.908 1.116 2.567 2.729 4.534 2.745 1.859 2.778 3.208 5.656 4.379
AD_3' ADHD 2.999 1.579 2.445 1.449 2.397 3.564 0.180 0.599 0.914 1.034 0.673 1.187 0.636 0.878 0.989 0.836 0.769
AD_4' ADHD 1.048 1.935 1.328 1.192 1.835 1.678 4.278 6.280 5.051 1.928 6.018 4.085
AD_5' ADHD 0.390 2.289 0.593 1.796 1.390 1.931 0.193 1.743 0.732 1.866 2.671 0.958 2.560 1.125 1.626 1.861 3.953 4.735
AD_6' ADHD 1.176 1.461 1.292 1.933 3.216 2.746 1.234 1.023 1.213 1.204 2.002 2.019 4.850 2.023 1.927 1.855 2.415 2.397
AD_7' ADHD 1.834 3.344 2.563 1.854 2.812 3.027 1.185 3.131 3.936 5.953 2.857 3.886 4.414 4.038 3.678 4.289
AD_8' ADHD 1.516 2.154 1.562 2.224 1.896 3.687 1.624 1.211 1.112 0.596 4.136 0.461 0.774 0.916 0.826 4.396 0.291 1.079
AD_9' ADHD 1.821 3.105 2.551 2.545 2.013 4.110 1.206 1.967 2.754 1.893 1.603 1.610 2.635 3.335 1.770 2.194 2.343
AS_1' Autism 1.945 1.901 2.038 3.805 1.556 1.914 2.371 3.701 2.018 2.117
AS_2' Autism 2.317 1.498 1.228 1.241 3.769 2.060 1.560 1.886 1.346 2.822 1.907 1.783 3.801 4.167 2.203 1.216 1.940 1.281
AS_3' Autism 1.032 0.040 0.722 0.571 1.584 2.491 0.902 0.502 0.093 1.591 1.523 0.160 0.613 1.122 2.231 1.226 1.699 2.535
AS_4' Autism 1.421 1.452 1.838 2.118 1.122 2.249 0.316 0.028 0.357 0.100 0.241 0.282 0.629 0.380 0.203 0.279 0.200
AS_5' Autism 1.988 2.125 1.944 1.557 2.962 2.052 2.461 1.227 0.861 5.297 1.722 1.770 2.572 2.508 5.582 1.506 2.744 5.052
AS_6' Autism 0.980 1.819 2.152 3.135 1.959 1.645 3.453 3.707 4.343 1.467 3.106 4.365 4.167 3.406 5.707
AS_7' Autism 1.049 2.315 1.980 3.263 3.274 5.104 2.957 5.310 5.634 5.966
AS_8' Autism 3.361 2.809 4.450 2.564 1.095 1.893 1.693 5.187 1.444 1.961 3.087 2.766 6.474 1.934 2.237
AS_9' Autism 0.614 1.101 0.756 1.062 0.966 1.114 1.068 0.912 1.045 3.642 2.119 0.720 3.330 2.017 1.111 1.969 5.092 5.948
AS_10' Autism 1.546 0.868 1.632 1.104 2.480 3.500 1.375 3.433 0.893 6.196 3.269 4.062 2.836 3.269 1.987 3.129 4.020
C_1' Control 0.217 0.194 0.285 1.721 2.854 2.390 0.067 0.542 1.177 3.913 2.706 2.044 1.443 5.875 3.021 4.554
C_2' Control 0.296 0.210 2.242 1.466 5.361 3.658 0.497 0.786 1.192 2.310 1.081 2.394 2.272 3.420 4.139 2.347
C_3' Control 1.351 2.421 1.508 3.656 1.756 4.119 1.269 0.319 0.225 0.302 0.790 0.067 0.305 1.660 0.366 1.009 0.192 0.084
C_4' Control 1.111 1.039 1.271 1.321 1.410 2.551 0.851 1.132 1.245 4.272 1.832 1.551 2.047 2.653 4.268 3.201 4.381 4.898
C_5' Control 0.666 0.936 0.774 1.160 1.013 1.573 0.901 0.760 2.422 1.184 1.728 0.863 0.987 3.716 1.212 1.849 1.315 1.465
C_6' Control 1.526 1.914 1.264 2.763 3.687 5.386 1.608 1.623 1.976 5.329 4.400 1.846 2.517 2.889 2.667 2.474 6.539
C_7' Control 1.727 1.456 2.024 3.513 2.173 0.928 0.459 0.536 0.731 1.943 0.447 0.403 0.504 1.153 2.491 0.448 0.801
C_8' Control 3.093 1.004 3.320 1.020 4.537 1.722 0.857 0.194 0.791 1.400 0.279 0.778 0.527 0.841 4.724 0.931 0.884
C_9' Control 2.469 4.176 3.288 4.176 4.551 2.722 1.737 0.026 2.581 2.678 0.791 2.427 0.026 4.112 1.033 1.281
C_10' Control 0.931 0.758 1.329 1.049 2.506 4.272 1.451 0.459 1.199 0.794 2.968 0.058 0.523 1.327 1.417 4.224 0.969 1.060





TABLE III (continued) 
  
20 4 25 124 34 122 11 53 87 59 92 68 60 86 58 97 72 77
F1_AD F2_AD F3_AD F4_AD F7_AD F8_AD Fz_AD P3_AD P4_AD P7_AD P8_AD POz_AD PO3_AD PO4_AD P9_AD P10_AD O1_AD O2_AD
AD_1' ADHD 0.098 0.148 0.169 0.164 0.304 0.489 0.085 0.194 0.283 0.394 0.437 1.108 0.657 0.768 0.338 0.326 2.124 1.416
AD_2' ADHD 0.143 0.093 0.474 0.098 0.787 0.121 0.103 0.349 0.338 0.611 0.745 0.509 0.648 0.480 0.663 0.482 0.959 1.035
AD_3' ADHD 0.484 0.247 0.269 0.216 0.267 0.282 0.637 0.012 0.051 0.075 0.167 0.124 0.171 0.063 0.097 0.090 0.128 0.099
AD_4' ADHD 0.052 0.136 0.135 0.072 0.236 0.132 0.909 0.649 0.314 0.219 0.532 0.409 1.670
AD_5' ADHD 0.127 0.584 0.102 0.350 0.093 0.220 0.060 0.252 0.452 0.267 0.402 0.122 0.223 0.125 0.199 0.119 0.443 0.502
AD_6' ADHD 0.479 0.172 0.669 0.154 0.252 0.135 0.251 0.261 0.366 0.306 0.850 0.525 0.483 0.372 0.316 0.794 0.710
AD_7' ADHD 1.700 0.505 2.929 0.754 1.217 2.558 3.227 3.648 3.013 3.141 3.331 3.324 3.390 3.674
AD_8' ADHD 0.813 0.761 0.791 0.736 0.884 0.823 0.864 0.502 0.274 0.692 2.561 0.267 0.415 0.600 0.743 2.366 0.172 0.234
AD_9' ADHD 0.132 1.595 0.206 0.234 0.323 0.273 0.457 1.518 0.785 1.028 1.177 0.747 0.733 0.641 1.269 1.087
AS_1' Autism 0.717 0.609 0.350 1.262 0.777 0.374 0.896 1.411 0.645 2.087
AS_2' Autism 0.051 0.046 0.056 0.052 0.068 0.086 0.064 0.072 0.046 0.142 0.115 0.126 0.302 0.132 0.184 0.081 0.153 0.131
AS_3' Autism 0.170 0.010 0.493 0.059 0.087 0.139 0.060 0.097 0.021 0.228 0.268 0.031 0.277 0.349 0.275 0.180 0.237 0.243
AS_4' Autism 2.470 1.384 2.486 2.030 1.568 0.310 0.036 0.286 0.022 0.113 0.267 0.300 0.328 0.203 0.168 0.076
AS_5' Autism 0.305 0.221 0.385 0.259 0.603 0.434 0.215 0.393 0.318 0.519 0.285 0.371 0.313 0.331
AS_6' Autism 0.146 0.243 0.399 0.470 0.356 0.169 0.315 0.318 0.358 0.114 0.301 0.518 0.978 0.301 0.329 0.561
AS_7' Autism 2.059 3.782 4.719 3.668 3.710 3.690 3.431 2.303 3.836 3.020 6.807 6.292
AS_8' Autism 0.472 0.447 0.344 0.473 0.890 0.307 0.182 0.028 0.087 0.073 0.081 0.212 0.047 0.138 0.155 0.115 0.109
AS_9' Autism 0.077 0.139 0.139 0.126 0.128 0.114 0.179 0.020 0.096 0.392 0.169 0.388 0.374 0.148 0.055 0.154 0.580 0.660
AS_10' Autism 0.122 0.207 0.278 0.306 0.408 0.942 0.217 2.210 0.118 0.853 0.400 3.212 1.661 0.253 0.598 0.094 1.157 1.120
C_1' Control 0.043 0.040 0.069 0.365 0.409 0.004 0.164 0.276 1.243 0.283 0.682 0.893 0.292 1.187 0.311
C_2' Control 0.089 0.067 0.685 0.277 0.397 0.155 0.148 0.162 0.376 0.351 0.373 0.450 0.534 0.900 0.458
C_3' Control 0.152 0.225 0.164 0.397 0.165 0.105 0.033 0.016 0.040 0.368 0.015 0.030 0.313 0.069 0.330 0.034 0.011
C_4' Control 0.139 0.116 0.112 0.115 0.112 0.242 0.136 0.220 0.086 0.166 0.202 0.654 0.422 0.226 0.229 0.286 0.412 0.533
C_5' Control 0.113 0.352 0.164 0.489 0.353 0.504 0.231 0.090 0.174 0.113 0.618 0.189 0.053 0.394 0.157 0.503 0.326 0.383
C_6' Control 0.264 0.308 0.081 0.436 0.301 0.386 0.090 0.273 0.222 0.555 0.984 0.292 0.431 0.265 0.159 0.265 0.631 0.943
C_7' Control 0.059 0.142 0.054 0.151 0.101 0.061 0.030 0.117 0.028 0.249 0.019 0.027 0.032 0.024 0.279 0.021 0.049
C_8' Control 1.008 0.195 1.161 0.222 0.270 0.772 0.127 0.147 0.033 0.146 0.203 0.048 0.156 0.046 0.110 0.765 0.103 0.107
C_9' Control 0.110 0.569 0.126 0.586 0.177 0.317 0.199 0.003 0.317 0.232 0.068 0.362 0.002 0.330 0.110 0.109
C_10' Control 0.093 0.120 0.072 0.173 0.587 0.290 0.122 0.077 0.115 0.126 0.317 0.012 0.080 0.129 0.251 0.545 0.141 0.108
C_11' Control 0.326 0.309 0.518 0.279 0.899 0.351 0.258 0.778 0.628 1.509 0.661 0.765 0.779 0.636
20 4 25 124 34 122 11 53 87 59 92 68 60 86 58 97 72 77
F1_EM F2_EM F3_EM F4_EM F7_EM F8_EM Fz_EM P3_EM P4_EM P7_EM P8_EM POz_EM PO3_EM PO4_EM P9_EM P10_EM O1_EM O2_EM
AD_1' ADHD 0.095 0.045 0.220 0.055 0.166 0.239 0.057 0.209 0.361 0.305 0.557 1.186 0.627 0.958 0.172 0.281 2.830 2.021
AD_2' ADHD 0.104 0.084 0.261 0.092 0.360 0.074 0.090 0.176 0.127 0.328 0.306 0.338 0.346 0.173 0.368 0.256 0.500
AD_3' ADHD 0.350 0.207 0.137 0.112 0.117 0.290 0.445 0.014 0.035 0.069 0.097 0.067 0.088 0.042 0.073 0.074 0.079 0.070
AD_4' ADHD 0.042 0.065 0.067 0.321 0.299 0.038 0.140 0.076 0.132 0.267 0.289 0.111 0.227 0.220 0.361 0.912
AD_5' ADHD 0.119 0.426 0.074 0.252 0.061 0.185 0.045 0.154 0.173 0.084 0.217 0.071 0.119 0.057 0.094 0.178 0.197 0.223
AD_6' ADHD 0.359 0.138 0.525 0.232 0.205 0.617 0.093 0.092 0.201 0.193 0.388 0.527 0.324 0.325 0.339 0.429 0.488 0.623
AD_7' ADHD 1.839 0.119 2.970 1.006 2.868 0.663 1.230 2.237 3.097 3.273 2.754 3.003 3.359 3.170 3.179 3.378
AD_8' ADHD 0.533 0.544 0.508 0.553 0.609 0.558 0.642 0.250 0.093 0.362 2.748 0.147 0.189 0.382 0.427 2.810 0.099 0.365
AD_9' ADHD 0.130 0.978 0.146 0.482 0.298 0.481 0.546 0.994 0.723 1.274 0.910 1.207 0.902 1.591 1.434
AS_1' Autism 0.140 0.233 0.156 0.482 0.246 0.136 0.522 0.532 0.276 0.629
AS_2' Autism 0.024 0.049 0.045 0.029 0.111 0.076 0.041 0.086 0.023 0.182 0.072 0.156 0.299 0.086 0.158 0.054 0.111 0.099
AS_3' Autism 0.065 0.010 0.300 0.056 0.107 0.133 0.092 0.038 0.010 0.098 0.062 0.019 0.068 0.109 0.165 0.067 0.043 0.067
AS_4' Autism 0.396 0.331 0.400 0.326 0.340 0.024 0.011 0.026 0.010 0.021 0.022 0.247 0.028 0.019 0.049 0.013
AS_5' Autism 0.076 0.194 0.133 0.149 0.151 0.204 0.210 0.091 0.059 0.485 0.222 0.107 0.238 0.113 0.468 0.100 0.284
AS_6' Autism 0.053 0.116 0.098 0.173 0.419 0.069 0.194 0.273 0.230 0.090 0.298 0.267 0.712 0.222 0.318 0.365
AS_7' Autism 0.212 0.676 0.699 0.677 0.392 1.161 0.910 1.459 1.621
AS_8' Autism 0.183 0.202 0.237 0.224 0.129 0.104 0.030 0.141 0.124 0.144 0.231 0.058 0.183 0.218 0.122 0.119
AS_9' Autism 0.050 0.077 0.085 0.062 0.099 0.060 0.045 0.041 0.041 0.107 0.057 0.189 0.113 0.054 0.052 0.082 0.157 0.190
AS_10' Autism 0.102 0.162 0.320 0.213 0.236 0.272 0.172 1.705 0.106 0.375 2.264 1.589 0.114 0.215 0.226 0.517 0.411
C_1' Control 0.027 0.017 0.043 0.123 0.215 0.002 0.100 0.131 0.413 0.170 0.359 0.410 0.138 0.506 0.104
C_2' Control 0.029 0.026 0.175 0.104 0.223 0.213 0.054 0.101 0.142 0.311 0.323 0.313 0.229 0.196 0.330 0.239
C_3' Control 0.065 0.068 0.071 0.101 0.071 0.035 0.015 0.014 0.020 0.074 0.009 0.015 0.297 0.032 0.098 0.032 0.007
C_4' Control 0.109 0.108 0.086 0.103 0.092 0.184 0.110 0.245 0.057 0.123 0.063 0.545 0.361 0.116 0.172 0.128 0.129 0.127
C_5' Control 0.053 0.225 0.106 0.311 0.275 0.434 0.177 0.082 0.053 0.088 0.535 0.153 0.054 0.382 0.123 0.471 0.347 0.377
C_6' Control 0.269 0.341 0.132 0.520 0.260 0.467 0.127 0.257 0.321 0.387 0.326 0.194 0.293 0.072 0.272 0.275 0.281 0.284
C_7' Control 0.025 0.054 0.031 0.154 0.040 0.213 0.049 0.036 0.023 0.028 0.105 0.007 0.036 0.026 0.035 0.125 0.033 0.026
C_8' Control 0.071 0.062 0.870 0.163 0.051 0.021 0.049 0.087 0.026 0.051 0.038 0.112 0.312 0.045 0.049
C_9' Control 0.081 0.186 0.115 0.191 0.131 0.141 0.070 0.001 0.101 0.111 0.033 0.115 0.001 0.453 0.145 0.046 0.052
C_10' Control 0.043 0.056 0.034 0.102 0.393 0.161 0.062 0.029 0.083 0.050 0.182 0.003 0.031 0.077 0.139 0.302 0.068 0.060





TABLE III (continued) 
  
20 4 25 124 34 122 11 53 87 59 92 68 60 86 58 97 72 77
F1_FS F2_FS F3_FS F4_FS F7_FS F8_FS Fz_FS P3_FS P4_FS P7_FS P8_FS POz_FS PO3_FS PO4_FS P9_FS P10_FS O1_FS O2_FS
AD_1' ADHD 0.287 0.214 0.475 0.189 0.176 0.322 0.258 0.192 0.490 0.275 0.648 1.345 0.619 1.209 0.155 0.181 3.445 3.037
AD_2' ADHD 0.125 0.174 0.214 0.215 0.248 0.124 0.187 0.300 0.053 0.448 0.241 0.649 0.472 0.170 0.476 0.192 0.679 0.381
AD_3' ADHD 0.481 0.365 0.223 0.146 0.152 0.595 0.610 0.017 0.046 0.061 0.210 0.062 0.097 0.057 0.061 0.097 0.070 0.072
AD_4' ADHD 0.142 0.304 0.104 0.220 0.114 0.095 0.575 0.392 0.104 0.306 0.685 1.024
AD_5' ADHD 0.181 0.502 0.118 0.367 0.197 0.379 0.054 0.213 0.122 0.160 0.581 0.176 0.318 0.114 0.116 0.437 0.569 0.669
AD_6' ADHD 0.704 0.395 0.956 0.488 0.329 0.286 0.238 0.205 0.693 0.219 0.695 0.701 0.404 0.674 0.397 0.607 0.765 1.097
AD_7' ADHD 2.216 0.331 3.309 1.132 3.379 0.775 1.320 2.004 3.199 3.023 2.655 3.118 3.467 3.263 3.259 3.103 3.228
AD_8' ADHD 0.490 0.547 0.462 0.558 0.604 0.715 0.749 0.179 0.243 0.248 3.446 0.122 0.128 0.332 0.366 3.887 0.072 0.588
AD_9' ADHD 0.350 0.814 0.231 0.841 0.359 0.783 0.431 1.218 0.740 1.190 0.938 1.560 1.058 1.718 1.843
AS_1' Autism 0.218 0.341 0.175 0.658 0.161 0.160 0.682 0.347 0.208 0.541
AS_2' Autism 0.062 0.091 0.087 0.064 0.275 0.153 0.079 0.172 0.046 0.349 0.117 0.217 0.392 0.189 0.219 0.096 0.192 0.166
AS_3' Autism 0.082 0.011 0.228 0.120 0.188 0.151 0.175 0.065 0.021 0.233 0.169 0.033 0.125 0.169 0.322 0.172 0.172 0.327
AS_4' Autism 1.009 0.842 1.007 1.086 0.728 1.073 0.098 0.008 0.104 0.014 0.061 0.098 0.315 0.126 0.028 0.109 0.040
AS_5' Autism 0.317 0.658 0.212 0.283 0.321 0.457 0.437 0.167 0.204 0.520 0.387 0.246 0.228 0.264 0.510 0.229 0.184
AS_6' Autism 0.075 0.162 0.071 0.346 0.688 0.079 0.328 0.399 0.355 0.116 0.505 0.330 0.937 0.350 0.559 0.534
AS_7' Autism 0.212 0.676 0.699 0.677 0.392 1.161 0.910 1.459 1.268 1.212 1.621
AS_8' Autism 0.396 0.395 0.260 0.655 0.842 0.308 0.189 0.130 0.247 0.423 0.192 0.564 0.168 0.394 0.599 0.302 0.292
AS_9' Autism 0.083 0.146 0.107 0.106 0.161 0.097 0.147 0.132 0.054 0.048 0.063 0.222 0.057 0.061 0.104 0.107 0.102 0.101
AS_10' Autism 0.121 0.276 0.406 0.344 0.265 0.403 0.291 1.906 0.100 0.691 2.132 0.172 0.448 0.374 0.956 0.938
C_1' Control 0.057 0.013 0.071 0.328 0.138 0.171 0.002 0.110 0.285 0.181 0.220 0.645 0.295 0.484 0.466
C_2' Control 0.044 0.045 0.219 0.168 0.279 0.353 0.095 0.110 0.188 0.445 0.322 0.445 0.372 0.275 0.522 0.362
C_3' Control 0.165 0.259 0.175 0.332 0.193 0.885 0.130 0.036 0.052 0.049 0.118 0.015 0.042 0.555 0.052 0.102 0.043 0.018
C_4' Control 0.151 0.199 0.122 0.234 0.144 0.347 0.145 0.406 0.089 0.277 0.092 0.588 0.363 0.467 0.331 0.330 0.221 0.171
C_5' Control 0.110 0.220 0.148 0.354 0.280 0.356 0.262 0.093 0.051 0.106 0.581 0.161 0.091 0.602 0.148 0.441 0.372 0.493
C_6' Control 0.324 0.362 0.185 0.631 0.461 0.771 0.171 0.480 0.573 0.634 0.249 0.735 0.138 0.663 0.402 0.548 0.661
C_7' Control 0.014 0.074 0.033 0.265 0.028 0.278 0.065 0.117 0.047 0.093 0.115 0.023 0.123 0.030 0.116 0.155 0.125 0.116
C_8' Control 0.291 0.290 0.439 0.114 0.048 0.126 0.293 0.083 0.127 0.139 0.202 1.026 0.171 0.181
C_9' Control 0.169 0.294 0.258 0.320 0.305 0.176 0.074 0.002 0.084 0.104 0.050 0.100 0.001 0.388 0.125 0.056 0.078
C_10' Control 0.059 0.045 0.053 0.095 0.378 0.178 0.073 0.029 0.115 0.068 0.255 0.005 0.032 0.099 0.154 0.429 0.096 0.091
C_11' Control 0.106 0.138 0.159 0.116 0.389 0.172 0.256 0.336 0.148 0.242 0.198 0.527 0.516
20 4 25 124 34 122 11 53 87 59 92 68 60 86 58 97 72 77
F1_GE F2_GE F3_GE F4_GE F7_GE F8_GE Fz_GE P3_GE P4_GE P7_GE P8_GE POz_GE PO3_GE PO4_GE P9_GE P10_GE O1_GE O2_GE
AD_1' ADHD 0.458 0.245 0.424 0.211 0.140 0.350 0.258 0.202 0.472 0.352 0.532 1.368 0.550 0.935 0.389 0.277 3.370 2.049
AD_2' ADHD 0.063 0.095 0.082 0.117 0.105 0.099 0.099 0.274 0.111 0.398 0.222 0.996 0.431 0.199 0.416 0.255 0.931 0.609
AD_3' ADHD 0.446 0.334 0.079 0.061 0.077 0.464 0.056 0.058 0.172 0.084 0.117 0.189 0.076 0.167 0.077 0.128 0.088
AD_4' ADHD 0.057 0.080 0.095 0.104 0.066 0.119 0.177 0.211 0.199 0.056 0.305 0.656
AD_5' ADHD 0.168 0.252 0.135 0.176 0.145 0.225 0.065 0.069 0.069 0.105 0.227 0.053 0.115 0.065 0.088 0.152 0.274 0.352
AD_6' ADHD 0.155 0.063 0.203 0.049 0.130 0.042 0.074 0.165 0.258 0.270 0.332 1.265 0.681 0.590 0.281 0.327 0.917 1.104
AD_7' ADHD 1.057 0.480 1.986 0.537 2.204 2.309 0.887 1.873 2.396 3.041 2.527 2.360 2.809 2.406 2.938 3.190
AD_8' ADHD 0.365 0.373 0.363 0.381 0.647 0.414 0.276 0.087 0.125 0.084 1.579 0.074 0.053 0.305 0.094 1.487 0.041 0.139
AD_9' ADHD 0.224 1.021 0.335 0.643 0.426 0.551 0.405 0.366 0.544 0.429 0.536 0.466 0.596 0.816 0.341 0.685 0.766
AS_1' Autism 0.111 0.275 0.120 0.547 0.117 0.113 0.408 0.242 0.219 0.285
AS_2' Autism 0.145 0.102 0.089 0.066 0.169 0.128 0.111 0.140 0.067 0.208 0.165 0.073 0.387 0.132 0.070 0.088 0.153 0.143
AS_3' Autism 0.083 0.005 0.221 0.044 0.060 0.078 0.085 0.036 0.018 0.091 0.138 0.024 0.053 0.126 0.110 0.094 0.081 0.134
AS_4' Autism 0.138 0.181 0.152 0.141 0.178 0.131 0.047 0.003 0.048 0.015 0.032 0.043 0.095 0.058 0.026 0.037 0.029
AS_5' Autism 0.085 0.168 0.059 0.136 0.093 0.186 0.093 0.146 0.021 0.430 0.124 0.327 0.533 0.144 0.421 0.083 0.269 2.007
AS_6' Autism 0.104 0.238 0.100 0.089 0.628 0.140 0.164 0.313 0.150 0.151 0.233 0.158 0.142 0.245 0.245
AS_7' Autism 0.086 0.171 0.133 0.268 0.492 0.546 0.256 0.430 0.440 0.416
AS_8' Autism 0.308 0.264 0.385 0.332 0.041 0.177 0.127 0.335 0.057 0.106 0.266 0.260 0.394 0.131 0.152
AS_9' Autism 0.042 0.076 0.066 0.040 0.085 0.046 0.090 0.077 0.036 0.089 0.042 0.037 0.094 0.039 0.070 0.077 0.095 0.104
AS_10' Autism 0.131 0.131 0.180 0.172 0.348 0.165 0.248 0.991 0.088 0.241 0.128 0.795 0.154 0.115 0.134 0.249 0.147
C_1' Control 0.016 0.012 0.022 0.049 0.170 0.096 0.003 0.075 0.038 0.264 0.147 0.210 0.046 0.369 0.108 0.418
C_2' Control 0.025 0.020 0.150 0.160 0.123 0.417 0.046 0.057 0.281 0.197 0.312 0.190 0.427 0.307 0.868 0.438
C_3' Control 0.232 0.388 0.257 0.443 0.303 0.328 0.196 0.059 0.022 0.064 0.058 0.008 0.057 0.198 0.084 0.077 0.031 0.009
C_4' Control 0.109 0.098 0.134 0.134 0.149 0.137 0.111 0.103 0.058 0.306 0.129 0.326 0.333 0.076 0.288 0.339 0.334 0.253
C_5' Control 0.078 0.084 0.076 0.149 0.115 0.231 0.098 0.140 0.069 0.068 0.406 0.155 0.059 0.461 0.088 0.397 0.346 0.361
C_6' Control 0.441 0.499 0.262 0.499 0.485 0.505 0.194 0.126 0.099 0.308 0.495 0.093 0.264 0.274 0.312 0.465 0.413
C_7' Control 0.117 0.139 0.087 0.217 0.111 0.106 0.030 0.035 0.059 0.222 0.054 0.031 0.098 0.061 0.276 0.031 0.082
C_8' Control 0.195 0.026 0.217 0.028 0.319 0.042 0.026 0.011 0.014 0.045 0.004 0.012 0.017 0.013 0.190 0.020 0.020
C_9' Control 0.094 0.156 0.130 0.163 0.117 0.092 0.096 0.001 0.090 0.113 0.010 0.085 0.001 0.178 0.031 0.021
C_10' Control 0.036 0.018 0.035 0.082 0.073 0.082 0.067 0.009 0.102 0.050 0.225 0.004 0.013 0.073 0.130 0.278 0.089 0.104
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